Document is current
Any future updates will be listed below
-
Authors
Hoehne, Carolin Luisa
Lohner, Alina
Salim, Yones
Terhart, Maria
Andersen, Wiebke
Angerhöfer, Cornelius
Moltrecht, Rüdiger
Scheuerecker, Florian
Maassen van den Brink, Antoinette
Raffaelli, Bianca https://orcid.org/0000-0001-9758-1494
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 31 December 2025
Accepted: 1 March 2026
First Online: 24 March 2026
Declarations
:
: Since this study does not involve direct human or animal subjects and all data were extracted from previously published studies, ethical approval or informed consent were not required.
: Not applicable.
: CLH, YS, WA, CA, FS, RM and AL have nothing to declare. MT reports personal from TEVA. AMvdB received honoraria, research and/or travel grants from Allergan/Abbvie, Amgen/Novartis, Eli Lilly, Organon, Pfizer, Satsuma and Teva as principal investigator. Intellectual as president of the European Headache Federation, associate editor for The Journal of Headache and Pain. BR is associate editor of The Journal of Headache and Pain and Cephalalgia, reports research grants from Novartis, Lundbeck, German Migraine and Headache Society (DMKG), German Research Foundation (DFG) and Else Kröner-Fresenius-Stiftung, and personal fees from Abbvie, Lundbeck, Novartis, Organon, Perfood and Teva.
